9BA0
| Structural mechanism of CB1R binding to peripheral and biased inverse agonists | Descriptor: | CNb36, Cannabinoid receptor 1,Glycogen synthase, N-(N-{(E)-[(4S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl][4-(trifluoromethyl)benzene-1-sulfonamido]methylidene}carbamimidoyl)acetamide | Authors: | Kumari, P, Szabolcs, D, Enos, M.D, Ramesh, K, Lim, D, Hassan, S.A, Kunos, G, Cinar, R, Iyer, M.R, Rosenbaum, D.M. | Deposit date: | 2024-04-03 | Release date: | 2024-11-20 | Method: | ELECTRON MICROSCOPY (3.13 Å) | Cite: | Structural mechanism of CB1R binding to peripheral and biased inverse agonists To Be Published
|
|
9B9Z
| Structural mechanism of CB1R binding to peripheral and biased inverse agonists | Descriptor: | (4S)-3-(4-chlorophenyl)-N'-[(1E)-ethanimidoyl]-4-phenyl-N-[4-(trifluoromethyl)benzene-1-sulfonyl]-4,5-dihydro-1H-pyrazole-1-carboximidamide, CNb36, Cannabinoid receptor 1,Glycogen synthase | Authors: | Kumari, P, Dvoracsko, S, Enos, M.D, Ramesh, K, Lim, D, Hassan, S.A, Kunos, G, Cinar, R, Iyer, M.R, Rosenbaum, D.M. | Deposit date: | 2024-04-03 | Release date: | 2024-11-20 | Method: | ELECTRON MICROSCOPY (3.3 Å) | Cite: | Structural mechanism of CB1R binding to peripheral and biased inverse agonists To Be Published
|
|